Application of fibroblast activation protein inhibitors in the diagnosis and treatment of nuclear medicine
10.3760/cma.j.cn321828-20200305-00090
- VernacularTitle:成纤维细胞激活蛋白抑制剂在核医学诊疗中的应用
- Author:
Guangyu MA
;
Baixuan XU
;
Jinming ZHANG
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2021;41(2):116-118
- CountryChina
- Language:Chinese
-
Abstract:
Fibroblast activation protein (FAP) is highly expressed in most epithelial tumors, and FAP inhibitors (FAPIs) have been used in tumor diagnosis and treatment. Taking FAP as the target, new kinds of tumor imaging and therapeutic radiopharmaceuticals can be developed. FAPIs have been used in the preclinical and clinical researches as the carrier of tumor imaging and treatment. This article reviews the research progress of FAPIs in nuclear medicine imaging and treatment.